Related Experiment Videos
Gene therapy for rheumatoid arthritis
E Gouze1, S C Ghivizzani, P D Robbins
1Center for Molecular Orthopaedics, Harvard Medical School, 221 Longwood Avenue, BL-152, Boston, MA 02115, USA.
Abstract:
Rheumatoid arthritis (RA) is a painful chronic disorder. Conventional therapies are palliative, not curative. Advances in the understanding of the pathophysiology of RA have led to the development of new therapeutic strategies, including gene therapy. Multiple studies in several different animal models provide proof supporting the use of gene therapy in arthritis. A phase I clinical trial has already been performed successfully on nine women with end-stage RA in the United States, and two other trials are in progress. Limited duration of gene expression impedes the development of a clinically useful genetic treatment for arthritis.
Insights
Gene therapy shows promise for rheumatoid arthritis (RA), with successful early trials. However, the short duration of gene expression remains a challenge for developing effective long-term genetic treatments for this chronic joint disorder.
Area of Science:
- Rheumatology and Gene Therapy
- Immunology and Molecular Biology
Background:
- Rheumatoid arthritis (RA) is a chronic, painful autoimmune disease with limited curative treatment options.
- Current therapies for RA primarily manage symptoms rather than addressing the underlying disease mechanisms.
- Advances in understanding RA pathophysiology have opened avenues for novel therapeutic strategies like gene therapy.
Purpose of the Study:
- To review the evidence supporting gene therapy as a treatment for arthritis.
- To highlight the progress and challenges in developing gene therapy for rheumatoid arthritis.
Main Methods:
- Review of preclinical studies in animal models of arthritis.
- Analysis of data from a completed Phase I clinical trial in women with end-stage RA.
- Inclusion of information on ongoing clinical trials for gene therapy in arthritis.
Main Results:
- Multiple animal studies demonstrate the potential of gene therapy in managing arthritis.
- A Phase I clinical trial involving nine women with end-stage RA was successfully completed.
- Two additional clinical trials investigating gene therapy for arthritis are currently underway.
Conclusions:
- Gene therapy presents a promising therapeutic avenue for rheumatoid arthritis, supported by preclinical and early clinical data.
- The primary limitation hindering the clinical application of gene therapy for arthritis is the transient nature of gene expression.
- Further research is needed to overcome the challenge of sustained gene expression for effective, long-term genetic treatment of RA.